SOLACI-CACI 2021 | TCT Session: The Future of PCI

✔️ Watch the TCT session in the Congreso SOLACI-CACI 2021.

👨‍🏫 Program:

  • 00:54 – The Future of PCI. Identification and treatment of vulnerable plaque – Gregg Stone
  • 32:50 – State of the Art: Intracoronary Imaging – Gary Mintz
  • 57:04 – DAPT: Today and Beyond – Roxana Mehran

✔️ Chairpersons: Aníbal Damonte & Alfredo E. Rodríguez.
✔️ Digital Moderator: Miguel Larribau.
✔️ Panelistas: Chavarría, Jorge – Feres, Fausto – Fernández, Alejandro Abel – Pérez de la Hoz, Ricardo -Rubilar, Bibiana – Veas, Nicolás.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...